$AWH News

Last published 1y ago

1y agoAWH AWHLAspira Women's Health Wins Laboratory Service Contract with University of Texas Medical Branch at GalvestonACCESS NewswireAspira Executes New, Scalable Laboratory Services Agreement in One of the Largest Markets in the US AUSTIN, TX AND WASHINGTON, DC / ACCESS Newswire / October 29, 2025 / Aspira Women's Health Inc., abio-analytical-based
1y agoAWH AWHLAspira Women's Health Appoints New Chief Financial OfficerACCESS NewswireNew Executive Brings 20+ Years of Accounting,Capital Markets & Biotechnology Experience AUSTIN, TX / ACCESS Newswire / September 4, 2025 / Aspira Women's Health Inc.
1y agoAWH AWHLAspira Women's Health Announces Appointment of Jane Pine Wood to the Board of DirectorsACCESS NewswireAUSTIN, TX / ACCESS Newswire / July 15, 2025 / Aspira Women's Health Inc. , an AI enhanced bio-analytical based women's health company focused on delivering the
1y agoAWH AWHLAspira Women's Health Partners with Dorsata to Offer Access to 300+ Women's Health Practices, 1.5 Million + New PatientsACCESS NewswireAspira and Dorsata Launch Clinical Workflow Tool for Adnexal Masses,Now Live for All Dorsata Clients, Adnexal Mass Evidence-Based Decision Support AUSTIN, TX AND WASHINGTON, DC / ACCESS Newswire / June 17, 2025 / Aspira
1y agoAWHAspira Women's Health Inc. to Begin Trading April 17th On OTC Under the Symbol "AWHL"ACCESS NewswireSHELTON, CT / ACCESS Newswire / April 17, 2025 / Aspira Women's Health Inc. , a bio-analytical based women's health company focused on the development of
1y agoAWHAspira Women's Health Inc. Announces Receipt of Delisting Notification from NasdaqACCESS NewswireSHELTON, CT / ACCESS Newswire / April 16, 2025 / Aspira Women's Health Inc. , a bio-analytical based women's health company focused on the development of
1y agoAWHAspira Appoints Three New Directors, Executes $2.0 Million Equity Purchase AgreementACCESS NewswireNew Directors Bring Extensive Commercial Healthcare Relationships to Expand Business Development Opportunities. AUSTIN, TX / ACCESS Newswire / April 8, 2025 / Aspira Women's Health Inc. ("Aspira" or the
1y agoAWHAspira Receives $1.5 million Milestone Payment from the ARPA-H Sprint for Women's Health AwardACCESS NewswireThe Company Successfully Reaches the Second Milestone of ARPA-H $10 Million Award AUSTIN, TX / ACCESS Newswire / March 31, 2025 / Aspira Women's Health Inc. , a bio-analytical based
1y agoAWHAspira Women's Health Reports Fourth Quarter and Full Year 2024 Financial ResultsACCESS NewswireRecord 2024 OvaSuite revenue of $9.2 million and volume of 24,305 units sold AUSTIN, TX / ACCESS Newswire / March 27, 2025 / Aspira Women's Health Inc. , a
1y agoAWHAspira Women's Health Announces Closing of $1.37 Million Private Placement of Convertible NotesACCESS NewswireAUSTIN, TX / ACCESS Newswire / March 11, 2025 / Aspira Women's Health Inc. , a bio-analytical based women's health company focused on the development of
1y agoAWHAspira Women's Health Submits Request for Withdrawal of Form S-1 Registration StatementACCESS NewswireAUSTIN, TX / ACCESS Newswire / February 13, 2025 / Aspira Women's Health Inc. , a bio-analytical based women's health company focused on the development of
1y agoAWHAspira Women's Health Announces Appointment of Ellen Beausang to the Board of DirectorsACCESS NewswireAUSTIN, TX / ACCESS Newswire / February 11, 2025 / Aspira Women's Health Inc. , a bio-analytical based women's health company focused on the development of
1y agoAWHAspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial OperationsACCESS NewswireInterim CFO John Kallassy to Depart January 10 AUSTIN, TX / ACCESSWIRE / January 10, 2025 / Aspira Women's Health Inc. , a bio-analytical based women's health
1y agoAWHAspira Women's Health Announces Appointment of Dr. Sandra Milligan as Interim CEOGlobeNewswireAUSTIN, Texas, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease
1y agoAWHAspira Women's Health Successfully Reaches the First Milestone of the ARPA-H $10 Million AwardGlobeNewswireAUSTIN, Texas, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools,
1y agoAWHAspira Women's Health Inc. (AWH) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
1y agoAWHAspira Women's Health Reports Selected Third Quarter 2024 Financial ResultsGlobeNewswireQ3 2024 OvaSuiteSM revenue of $2.3 million and volume of 6,001 units Cash utilization for the third quarter was $2.9 million, a decrease of 12% compared to the second quarter of 2024 Full year 2024 cash guidance
2y agoAWH OPKAspira Women's Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®GlobeNewswireAUSTIN, Texas, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools,
2y agoAWHAspira Women's Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024GlobeNewswireAUSTIN, Texas, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease
2y agoAWHAspira Women's Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024GlobeNewswireAUSTIN, Texas, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, has
2y agoAWHAspira Women's Health Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's HealthGlobeNewswireAUSTIN, Texas, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools,
2y agoAWHAspira Women's Health Receives Approval from New York State Department of Health for OvaWatch®GlobeNewswireAUSTIN, Texas, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools,
2y agoAWHAspira Women's Health Announces Publication of Data Demonstrating Performance of its In-Development Blood Test for the Assessment of Malignancy Risk in Patients with an Adnexal MassGlobeNewswireAUSTIN, Texas, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools,
2y agoAWHAspira Women's Health to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceGlobeNewswireAUSTIN, Texas, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools,
2y agoAWHAspira Women's Health Selected as a Spoke for the Investor Catalyst HubGlobeNewswireAUSTIN, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools,
2y agoAWHAspira Women's Health Partners with Dorsata to Create New Clinical Workflow Tool for Adnexal MassesGlobeNewswireAUSTIN, Texas, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools,
2y agoAWHAspira Women's Health Inc. (AWH) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoAWHAspira Women's Health Reports Second Quarter 2024 Financial ResultsGlobeNewswireQ2 2024 OvaSuiteSM revenue of $2.4 million and volume of 6,471 units Q2 2024 cash utilization decreased by 16% compared to Q1 2024 Full year 2024 cash guidance decreased to $13-$14.5 million Conference Call and
2y agoAWHAspira Women's Health's Announces a Poster Presentation at the 27th Annual National Association of Nurse Practitioners in Women's Health (NPWH) Women's Healthcare ConferenceGlobeNewswireAUSTIN, Texas, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools,
2y agoAWHAspira Women's Health Announces Poster Presentation at the Menopause Society's 2024 Annual MeetingGlobeNewswireAUSTIN, Texas, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools,
2y agoAWHAspira Women's Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 12GlobeNewswireAUSTIN, Texas, July 31, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease
2y agoAWHAspira Women's Health Appoints Mr. John Ragard to its Board of DirectorsGlobeNewswireAUSTIN, Texas, July 29, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools,
2y agoAWHAspira Women's Health Announces Preliminary Second Quarter 2024 OvaSuite Product Volume and HighlightsGlobeNewswirePreliminary OvaWatch® volume during Q2 2024 grew 24% over the prior quarter to 1,307 units Preliminary OvaSuiteSM volume during Q2 2024 grew 11% over the prior quarter to 6,471 units AUSTIN, Texas, July 11, 2024
2y agoAWHAspira Women's Health Announces Closing of $1.9 Million Private Placement Equity FinancingGlobeNewswireAUSTIN, Texas, July 09, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease
2y agoAWHAspira Women's Health Announces $1.935 Million Private Placement Equity FinancingGlobeNewswireAUSTIN, Texas, July 01, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease
2y agoAWHAspira Women's Health Provides Commercial, Reimbursement and Cash Guidance UpdatesGlobeNewswireMonthly OvaSuiteSM product volume grew by more than 26% in May compared to January Reimbursement momentum continued with expanded Anthem and Medicaid coverage for OvaSuite Cash used in operations guidance for 2024
2y agoAWHAspira Women's Health to Present at the A.G.P. Healthcare Showcase on May 21GlobeNewswireAUSTIN, Texas, May 16, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease
2y agoAWHAspira Women's Health Inc. (AWH) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoAWHAspira Women's Health Reports First Quarter 2024 Financial ResultsGlobeNewswireQ1 2024 OvaSuiteSM revenue of $2.2 million and volume of 5,829 units Q1 2024 cash utilization of $4.4 million, a decrease of 22% compared to Q1 2023 Conference Call and Webcast scheduled for today at 8:30 am ET
2y agoAWHAspira Women's Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15GlobeNewswireAUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease
2y agoAWHAspira Women's Health Announces Publication of Two OvaWatch Peer-Reviewed ManuscriptsGlobeNewswireAUSTIN, Texas, May 07, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease
2y agoAWHAspira Women's Health Enhances its Commercial Offering with the Formal Launch of Longitudinal Monitoring Feature of OvaWatchGlobeNewswireAUSTIN, Texas, May 02, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease
2y agoAWHAspira Women's Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in CaliforniaGlobeNewswireAUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease
2y agoAWHAspira Women's Health Inc. (AWH) Q4 2023 Earnings Call TranscriptEarnings Call Transcripts
2y agoAWHAspira Women's Health Reports Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewswire2023 OvaSuite revenue of $9.2 million, an increase of 15% year-over-year 2023 OvaSuite volume of 23,990 units, an increase of 12% year-over-year Cash utilization declined in both the fourth quarter and full-year
2y agoAWHAspira Women's Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and CallGlobeNewswireAUSTIN, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease
2y agoAWHAspira Women's Health to Present at the MedInvest Biotech & Pharma Investor ConferenceGlobeNewswireAUSTIN, Texas, March 21, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease
2y agoAWHAspira Women's Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as PresidentGlobeNewswireDr. Milligan brings a wealth of experience across critical business functions and deep relationships with leaders throughout the healthcare and pharmaceutical sectors Aspira also announces Dr. Todd Pappas, Vice
2y agoAWHAspira Women's Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024GlobeNewswireAUSTIN, Texas, March 11, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease
2y agoAWHAspira Women's Health to Present at The Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer ConferenceGlobeNewswireAUSTIN, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease